30^th Annual European Pharma Congress May 18-19, 2020 Berlin, Germany

Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in Internal Medicine at the Massachusetts General Hospital, a Harvard Hospital, in Boston. He was also a Pharmacology Research Associate at the National Institutes of Health (NIH) in the laboratory of Nobel Laureate Dr. Julius Axelrod. He is presently Professor of Pharmacology and Medicine at the Mayo Clinic Medical School. He also Co-Directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine.

Dr. Weinshilboum’s research has focused on pharmacogenomics, with over 470 published manuscripts on that topic. In recent decades he has applied genome-wide genomics and other “omics” techniques to study drug response—for example, the drug therapy of depression. Dr. Weinshilboum has been the recipient of many awards including an Established Investigatorship of the American Heart Association, a Burroughs Wellcome Scholar Award in Clinical Pharmacology, the Oscar B. Hunter Award of the American Society for Clinical Pharmacology and Therapeutics, the ASPET Harry Gold Award, the Edvard Poulsson Award from the Norwegian Pharmacology Society and an honorary Doctor of Science degree from the University of Kansas. Dr. Weinshilboum has served as a member of the Advisory Councils for two US NIH Institutes, the National Institute for General Medical Sciences (NIGMS)—the NIH Institute where Pharmacology is based--and the National Human Genome Research Institute (NHGRI)—the NIH Institute that sponsored the Human Genome Project.

Dr. Liewei Wang received her medical degree from FuDan University Medical School, Shanghai, followed by a PhD degree in Pharmacology from the Mayo Clinic. She trained in a leading national center for pharmacogenomics (PGx) research. Currently Dr. Wang is Professor of Pharmacology at Mayo where she has developed a research program focused on the use of genomic technology joined with a cell-based model system and clinical samples to study mechanisms of cancer biology and drug response. As Co-PI of the Mayo-NIH Pharmacogenomics Research Network (PGRN) grant for the past decade she has led PGx functional genomic studies of breast cancer designed to identify and understand biomarkers for response to endocrine and chemotherapy of breast cancer.

Dr. Wang has published extensively in high impact journals and has received the Astellas Award from Astellas Foundation and the 2016 Leon Goldberg Early Investigator Award from the American Society for Clinical Pharmacology and Therapeutics.

Dr. Bimal Roy Krishna is currently Professor and Director of Pharmacology at the College of Osteopathic Medicine, Touro University in Nevada. He obtained a Bachelor of Science (First Class Honors) in Pharmacology and Physiology and a Doctor of Philosophy, Medicine (OB/GYN/Pharmacology) from Monash University in Australia. Dr. Krishna also teaches for the Step 1 USMLE and COMLEX reviews for Kaplan Medical throughout the United States and in UAE, Europe, Saudi Arabia, India, Mexico and the Caribbean. He has been teaching online for Kaplan University for over 7 years. He has contributed to numerous publications and is a member of a number of organizations including Fellow-American College of Clinical Pharmacology.

His research background is in maternal and neonatal pharmacology specifically looking at materno-fetal transfer utilizing the perfused human placental and cultured syncytiotrophoblast model. Complementary and Alternative medicine is another area of interest.

Dr. Qingyu Zeng has 25 years of extensive working experience. Throughout his career, Qingyu has served in various roles such as fellow, technical director, and advanced technology platform leader with various responsibilities to strategically lead many multi discipline team efforts to identify, evaluate, and develop cutting-edge products and core technologies for successful commercial platform deployment. He holds more than 10 granted patents. Qingyu graduated with BS and MS from Donghua University in China, received his Ph.D. in Polymer Science from North Carolina State University, and completed his EMBA from Ohio State University.

1

Dr. Liewei Wang received her medical degree from FuDan University Medical School, Shanghai, followed by a PhD degree in Pharmacology from the Mayo Clinic. She trained in a leading national center for pharmacogenomics (PGx) research. Currently Dr. Wang is Professor of Pharmacology at Mayo where she has developed a research program focused on the use of genomic technology joined with a cell-based model system and clinical samples to study mechanisms of cancer biology and drug response. As Co-PI of the Mayo-NIH Pharmacogenomics Research Network (PGRN) grant for the past decade she has led PGx functional genomic studies of breast cancer designed to identify and understand biomarkers for response to endocrine and chemotherapy of breast cancer.

Dr. Wang has published extensively in high impact journals and has received the Astellas Award from Astellas Foundation and the 2016 Leon Goldberg Early Investigator Award from the American Society for Clinical Pharmacology and Therapeutics.

Professor Dr. Heyam Saad Ali, She used to work as a head of pharmaceutics department in Dubai Pharmacy College, UAE. Currently, she is working in University of Khartoum, Faculty of Pharmacy, Pharmaceutics Department, Prof. contributed more than 70 articles to reputed international scientific journals and invited as speaker in many conferences. The subjects of interest include: different types of conventional, controlled and targeted drug delivery systems in nanotechnology, pharmaceutical product development, Quality control, Quality assurance and GMP in pharmaceutical industry. She has been invited as speaker to numerous International conferences. In, addition of being Editor, Reviewer and member of editorial board of many international journals

RR

Mahek Arora has a working experience of more than 9 years in academics and industry. She is pursuing her PhD at the age of 35 years from Amity University. She has been working on Drug monitoring for over 3 years. She has been awarded with many awards including Young Scientist award at a National conference. She has attended various conferences at International and national level including 4th International conference and exhibition on Phamacovigilance & Clinical Trials, held on August 10-12, 2015 at London where she was conferred for the certificate of Appreciation. She a more than 8 National and International Research papers to her credit.

PP

Mahek Arora has a working experience of more than 9 years in academics and industry. She is pursuing her PhD at the age of 35 years from Amity University. She has been working on Drug monitoring for over 3 years. She has been awarded with many awards including Young Scientist award at a National conference. She has attended various conferences at International and national level including 4th International conference and exhibition on Phamacovigilance & Clinical Trials, held on August 10-12, 2015 at London where she was conferred for the certificate of Appreciation. She a more than 8 National and International Research papers to her credit.

pp

Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in Internal Medicine at the Massachusetts General Hospital, a Harvard Hospital, in Boston. He was also a Pharmacology Research Associate at the National Institutes of Health (NIH) in the laboratory of Nobel Laureate Dr. Julius Axelrod. He is presently Professor of Pharmacology and Medicine at the Mayo Clinic Medical School. He also Co-Directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine.

Dr. Weinshilboum’s research has focused on pharmacogenomics, with over 470 published manuscripts on that topic. In recent decades he has applied genome-wide genomics and other “omics” techniques to study drug response—for example, the drug therapy of depression. Dr. Weinshilboum has been the recipient of many awards including an Established Investigatorship of the American Heart Association, a Burroughs Wellcome Scholar Award in Clinical Pharmacology, the Oscar B. Hunter Award of the American Society for Clinical Pharmacology and Therapeutics, the ASPET Harry Gold Award, the Edvard Poulsson Award from the Norwegian Pharmacology Society and an honorary Doctor of Science degree from the University of Kansas. Dr. Weinshilboum has served as a member of the Advisory Councils for two US NIH Institutes, the National Institute for General Medical Sciences (NIGMS)—the NIH Institute where Pharmacology is based--and the National Human Genome Research Institute (NHGRI)—the NIH Institute that sponsored the Human Genome Project.

1

1

Dr. Ahmad Ghorbani was born on 1976 and received his PhD degree in Medical Physiology from the Shiraz University of Medical Sciences, Iran. Currently, he is working as Research Associate Professor in Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences (MUMS), Iran. His areas of research include regenerative pharmacology and also phytopharmacology.

Dr. Ghorbani has received several honors and awards from MUMS, such as: the best young researcher award for the years 2012 and 2016, the best researcher in the field of pharmacology for the years 2014 and 2018, and the top 1% of researchers of MUMS for the year 2013. Also, he is one of the top 1% of reviewers in the field of pharmacology and toxicology for the year 2019 (powered by Publons). He published more than 115 papers and presented his studies in more than 35 congresses.

Mahek Arora has a working experience of more than 9 years in academics and industry. She is pursuing her PhD at the age of 35 years from Amity University. She has been working on Drug monitoring for over 3 years. She has been awarded with many awards including Young Scientist award at a National conference. She has attended various conferences at International and national level including 4th International conference and exhibition on Phamacovigilance & Clinical Trials, held on August 10-12, 2015 at London where she was conferred for the certificate of Appreciation. She a more than 8 National and International Research papers to her credit.

pp